Ind-Swift Limited has announced a significant milestone for its 100% Export Oriented Unit (Global Business Unit – GBU) located in Jawaharpur, Industrial Area, Dera Bassi, Punjab. The unit has successfully received the Certificate of Good Manufacturing Practice (GMP) Compliance from ROF Germany.
Key Details:
- Certification Details: Valid for the manufacturing of Metformin tablets in strengths of 500 mg, 750 mg, and 1000 mg.
- Inspection Period: Conducted between November 27 and December 4, 2024.
- Certificate Validity: Effective until June 3, 2026.
This certification underscores Ind-Swift’s commitment to maintaining high-quality standards in pharmaceutical manufacturing, boosting its export capabilities and global presence. The company informed the stock exchanges, BSE and NSE, of this development in compliance with SEBI’s listing obligations and disclosure norms.
